Table 2

Catheterisation data for TAVI implant procedures

Lotus (n=29)CoreValve (n=37)P value*
TAVI size (n(%))23 mm (7 (24%))
25 mm (8 (28%))
27 mm (14 (48%))
23 mm (4 (11%))
26 mm (8 (22%))
29 mm (18 (49%))
31 mm (7 (19%))
Femoral route, n (%)29 (100)27 (73)0.081
Sheath size (French)18 (28%)
20 (52%)
22 (20%)
18 (100%)
Pullback PG (mm Hg)56±2743±19 0.023
Fluoroscopy time (min)29±818±11 0.001
Procedure time (min)159±42143±500.194
Contrast (ml)120±43134±430.212
Predilatation BAV, n (%)25 (86)28 (77)0.286
Postdilatation, n (%)0 (0)5 (14) 0.039
TAVI repositioned, n (%)7 (24)0 (0) 0.002
TAVI embolisation, n (%)0 (0)3 (8)0.117
Need for second TAVI, n (%)0 (0)3 (8)0.117
  • *Independent samples t-test

  • PG, pressure gradient; BAV, balloon aortic valvuloplasty; TAVI, transcatheter aortic valve implantation.